An anti-parasite pill just got endorsed by Joe Rogan | Fortune
Pfizer's (PFE) Paxlovid Covid Pill Is Easier to Get as Omicron Fades Away - Bloomberg
The FDA will soon decide on Merck's Covid-19 antiviral pill. It shows promise, but there are also concerns | CNN
S.F. health officials turned away thousands of life-saving COVID pills, now plead with public to use them
Paxlovid: Pfizer's anti-COVID pill used by Joe Biden expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut | Fortune
Factbox: China's approved COVID treatments | Reuters
Study: Pfizer COVID pill showed no benefit in younger adults
Long COVID Treatment: Can Paxlovid Help?
Insight: Merck's COVID pill is last choice for U.S. patients, global use varies | Reuters
Pfizer Paxlovid Covid Pill Will Soon Be Available Across the U.S. - Bloomberg
Where Can I Get COVID-19 Pills? - GoodRx
Paxlovid: How to Get the COVID-19 Antiviral Drug
Japan Is Racing to Test Favipiravir, a Drug to Treat Covid-19 | WIRED
What to know about Paxlovid, the COVID-19 therapy that Biden is taking - ABC News
A federal program to ease access to Covid-19 antivirals rolls out, but pills have been going unused in many parts of the United States | CNN
FDA authorizes Merck's Covid-19 pill, but stresses its use should be limited
Pfizer's Covid-19 Pill Failed Study Testing Its Preventive Use - WSJ
How antiviral pill molnupiravir shot ahead in the COVID drug hunt
FDA staff: Pfizer's Covid treatment Paxlovid appears effective to use in high-risk adults
Paxlovid for COVID-19: Essential Info
/cloudfront-us-east-1.images.arcpublishing.com/gray/CEZK27HPKRAPNOJXBCPCPZOY5U.png "COVID-19 pill Paxlovid moves closer to full FDA approval")
COVID-19 pill Paxlovid moves closer to full FDA approval
As Covid-19 Pills Roll Out, Worry Mounts That Resistance Could Develop - WSJ
How to Get Paxlovid if You Have COVID — With or Without Health Insurance | KQED
Could a popular COVID-19 antiviral supercharge the pandemic? | Science | AAAS
COVID antivirals: Supply is increasing. Use isn't - CalMatters
